Yu‐Ning Wong

7.2k total citations · 3 hit papers
130 papers, 5.1k citations indexed

About

Yu‐Ning Wong is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Yu‐Ning Wong has authored 130 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Pulmonary and Respiratory Medicine, 45 papers in Oncology and 39 papers in Surgery. Recurrent topics in Yu‐Ning Wong's work include Bladder and Urothelial Cancer Treatments (31 papers), Renal cell carcinoma treatment (23 papers) and Economic and Financial Impacts of Cancer (23 papers). Yu‐Ning Wong is often cited by papers focused on Bladder and Urothelial Cancer Treatments (31 papers), Renal cell carcinoma treatment (23 papers) and Economic and Financial Impacts of Cancer (23 papers). Yu‐Ning Wong collaborates with scholars based in United States, France and Italy. Yu‐Ning Wong's co-authors include Brian L. Egleston, Robert G. Uzzo, J. Robert Beck, Richard L. Theriault, Jane C. Weeks, Joyce C. Niland, Stephen B. Edge, Melissa E. Hughes, Douglas W. Blayney and Eric P. Winer and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of the American Statistical Association.

In The Last Decade

Yu‐Ning Wong

126 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Why Summary Comorbidity Measures Such As the Charlson Comorbidity Index and Elixhauser Score Work

2013 539 citations Yu‐Ning Wong, Robert G. Uzzo et al. Medical Care profile →
Clinicopathologic features, patterns of recurrence, and survival among women with triple‐negative breast cancer in the National Comprehensive Cancer Network

2012 475 citations Melissa E. Hughes, Richard L. Theriault et al. Cancer profile →
Time to Surgery and Breast Cancer Survival in the United States

2015 429 citations Richard J. Bleicher, Karen Ruth et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yu‐Ning Wong United States	36	2.1k	1.7k	1.4k	1.1k	886	130	5.1k
Francesco Perrone Italy	38	3.6k 1.7×	1.8k 1.1×	870 0.6×	567 0.5×	1.1k 1.2×	188	5.9k
Stefano Rosso Italy	19	2.8k 1.3×	1.6k 1.0×	823 0.6×	1.0k 0.9×	1.1k 1.3×	37	5.7k
Francisco Vera-Badillo Canada	27	3.4k 1.6×	1.6k 1.0×	1.2k 0.9×	902 0.8×	754 0.9×	76	5.5k
Rajendra Badwe India	33	3.2k 1.5×	1.1k 0.7×	1.3k 0.9×	1.2k 1.1×	533 0.6×	183	5.6k
Esther Bastiaannet Netherlands	45	4.5k 2.1×	1.6k 0.9×	1.8k 1.2×	1.6k 1.5×	847 1.0×	263	6.9k
Amanda L. Blackford United States	48	3.6k 1.7×	1.4k 0.8×	1.3k 0.9×	941 0.9×	1.7k 1.9×	227	7.5k
Xianglin L. Du United States	46	4.0k 1.9×	1.6k 0.9×	1.0k 0.7×	817 0.8×	520 0.6×	216	7.4k
Marianne Ulcickas Yood United States	42	2.9k 1.4×	1.1k 0.6×	1.0k 0.7×	584 0.5×	378 0.4×	121	6.1k
Lynne Penberthy United States	21	1.8k 0.9×	942 0.6×	838 0.6×	465 0.4×	811 0.9×	36	5.3k
Annalisa Trama Italy	30	2.3k 1.1×	1.9k 1.1×	575 0.4×	1.1k 1.0×	605 0.7×	121	5.3k

Countries citing papers authored by Yu‐Ning Wong

Since Specialization

Citations

This map shows the geographic impact of Yu‐Ning Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Ning Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Ning Wong more than expected).

Fields of papers citing papers by Yu‐Ning Wong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Ning Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Ning Wong. The network helps show where Yu‐Ning Wong may publish in the future.

Co-authorship network of co-authors of Yu‐Ning Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Ning Wong. A scholar is included among the top collaborators of Yu‐Ning Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Ning Wong. Yu‐Ning Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hung, Anna, Julie A. Lynch, Tori Anglin-Foote, et al.. (2023). Development and Validation of a Tool to Identify Patients Diagnosed With Castration-Resistant Prostate Cancer. JCO Clinical Cancer Informatics. 7(7). e2300085–e2300085. 2 indexed citations

Lynch, Julie A., J M Petersen, Lori Hoffman-Hōgg, et al.. (2023). On-Site Nurse-Led Cancer Genetics Program Increases Cancer Genetic Testing Completion in Black Veterans. JCO Oncology Practice. 19(8). 637–644. 6 indexed citations

Egleston, Brian L., et al.. (2018). Temporal trends and characteristics of clinical trials for which only one racial or ethnic group is eligible. Contemporary Clinical Trials Communications. 9. 135–142. 3 indexed citations

Egleston, Brian L., Robert G. Uzzo, & Yu‐Ning Wong. (2016). Latent Class Survival Models Linked by Principal Stratification to Investigate Heterogenous Survival Subgroups Among Individuals With Early-Stage Kidney Cancer. Journal of the American Statistical Association. 112(518). 534–546. 7 indexed citations

Ghatalia, Pooja, Samuel Litwin, Eric M. Horwitz, et al.. (2016). Small-Cell Carcinoma of the Bladder: 20-Year Single-Institution Retrospective Review. Clinical Genitourinary Cancer. 15(3). e337–e343. 16 indexed citations

Miron, Benjamin, Benjamin T. Ristau, Jeffrey Tomaszewski, et al.. (2016). Biology is Destiny: A Case of Adrenocortical Carcinoma Diagnosed and Resected at Inception in a Patient Under Close Surveillance for Lung Cancer. Urology Case Reports. 9. 9–11.

Ruth, Karen, Elin R. Sigurdson, Brian L. Egleston, et al.. (2014). Skin Involvement and Breast Cancer: Are T4b Lesions of All Sizes Created Equal?. Journal of the American College of Surgeons. 219(3). 534–544. 15 indexed citations

Wong, Yu‐Ning, et al.. (2013). Why Summary Comorbidity Measures Such As the Charlson Comorbidity Index and Elixhauser Score Work. Medical Care. 53(9). e65–e72. 539 indexed citations breakdown →

Freedman, Rachel A., Melissa E. Hughes, Rebecca A. Ottesen, et al.. (2012). Use of adjuvant trastuzumab in women with human epidermal growth factor receptor 2 (HER2)‐positive breast cancer by race/ethnicity and education within the National Comprehensive Cancer Network. Cancer. 119(4). 839–846. 60 indexed citations

10.

Maughan, Benjamin L., Kenneth M. Boucher, Neeraj Agarwal, et al.. (2012). Correlation of progression-free survival at 6 months (PFS6) with overall survival at 12 months (OS12) in an analysis of 10 trials of second-line therapy for advanced urothelial carcinoma (UC).. Journal of Clinical Oncology. 30(15_suppl). 4525–4525. 3 indexed citations

11.

Wong, Yu‐Ning, Rebecca A. Ottesen, Melissa E. Hughes, et al.. (2011). Continued Use of Trastuzumab Beyond Disease Progression in the National Comprehensive Cancer Network: Should We Practice Ahead of the Evidence?. The Oncologist. 16(5). 559–565. 7 indexed citations

12.

Wong, Yu‐Ning & Elliot J. Coups. (2011). Correlates of Colorectal Cancer Screening Adherence Among Men Who have been Screened for Prostate Cancer. Journal of Cancer Education. 26(2). 301–307. 8 indexed citations

13.

Ruth, Karen, Mark K. Buyyounouski, Robert G. Uzzo, et al.. (2011). Prostate-specific antigen doubling time predicts the development of distant metastases for patients who fail 3-dimensional conformal radiotherapy or intensity modulated radiation therapy using the Phoenix definition. Practical Radiation Oncology. 1(4). 235–242. 17 indexed citations

14.

Alderman, Amy K., E. Dale Collins, Anne F. Schott, et al.. (2010). The impact of breast reconstruction on the delivery of chemotherapy. Cancer. 116(7). 1791–1800. 57 indexed citations

15.

Wong, Yu‐Ning, Byungse Suh, Rosaleen Parsons, et al.. (2009). Emphysematous Pyelonephritis Caused by Pasteurella multocida. 26(2). 60–62. 2 indexed citations

16.

Min, Hua, et al.. (2009). Integration of prostate cancer clinical data using an ontology. Journal of Biomedical Informatics. 42(6). 1035–1045. 46 indexed citations

17.

Kutikov, Alexander, Robert G. Uzzo, Brian L. Egleston, et al.. (2009). Use of systemic therapy and factors affecting survival for patients undergoing cytoreductive nephrectomy. British Journal of Urology. 106(2). 218–223. 42 indexed citations

18.

Wong, Yu‐Ning, Stephen J. Freedland, Brian L. Egleston, et al.. (2009). The Role of Primary Androgen Deprivation Therapy in Localized Prostate Cancer. European Urology. 56(4). 609–616. 43 indexed citations

19.

Wong, Yu‐Ning, Neal J. Meropol, William Speier, et al.. (2009). Cost implications of new treatments for advanced colorectal cancer. Cancer. 115(10). 2081–2091. 54 indexed citations

20.

Crispen, Paul L., et al.. (2008). Pathologic Concordance of Sporadic Synchronous Bilateral Renal Masses. Urology. 72(1). 138–142. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact